PILOT STUDY OF ADJUVANT FRAMELESS STEREOTACTIC RADIOTHERAPY (FSR) TO THE SURGICAL CAVITY IN PATIENTS WITH BRAIN METASTASES.

被引:0
|
作者
Freixa, S. Villa [1 ,2 ]
Hostalot, C. [1 ]
Linero, D. [1 ]
Escude, L. [1 ]
Canales, S. [1 ]
Arnalte, R. [1 ]
Vargas, E. [1 ]
Toscas, I. [1 ]
Jorcano Picart, S. [1 ]
Miralbell, R. [1 ,3 ]
机构
[1] Inst Oncol Teknon, Barcelona, Spain
[2] Catalan Inst Oncol Badalona, Radiat Oncol, Barcelona, Spain
[3] Univ Geneva, Hop Cantonal, Geneva 14, Switzerland
关键词
D O I
10.1016/S0167-8140(11)71087-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
965
引用
收藏
页码:S367 / S367
页数:1
相关论文
共 50 条
  • [21] Radiotherapy of brain metastases. Relationship with patients age an Karnofsky Index
    Monroy Anton, J. L.
    Albestain Maria, J.
    Cuenca Torres, M.
    Lopez Munoz, M.
    Soler Tortosa, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S490 - S490
  • [22] Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastases
    De Potter, Bruno
    De Meerleer, Gert
    De Neve, Wilfried
    Boterberg, Tom
    Speleers, Bruno
    Ost, Piet
    NEUROLOGICAL SCIENCES, 2013, 34 (05) : 647 - 653
  • [23] CAVITY RADIOSURGERY AND STEREOTACTIC HYPOFRACTIONATED RADIOTHERAPY AS ADJUVANT THERAPY AFTER RESECTION OF CEREBRAL METASTASES
    Broemme, J. O.
    Schucht, P.
    Beck, J.
    Abu-Isa, J.
    Kottke, R.
    Malthaner, M.
    Schmidthalter, D.
    Aebersold, D. M.
    Pica, A.
    NEURO-ONCOLOGY, 2012, 14 : 78 - 78
  • [24] Cavity radiosurgery and stereotactic hypofractionated radiotherapy as adjuvant therapy after resection of cerebral metastases
    Broemme, J.
    Schucht, P.
    Beck, J.
    Abu-Isa, J.
    Kottke, R.
    Malthaner, M.
    Schmidthalter, D.
    Aebersold, D. M.
    Pica, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (08) : 729 - 729
  • [25] SALVAGE FRAMELESS STEREOTACTIC RADIOSURGERY AS FIRST TREATMENT OPTION FOR RECURRENT BRAIN METASTASES. MAY DURABLE INTRACRANIAL CONTROL BE ACHIEVED?
    Jablonska, P. A.
    Gimeno, M.
    Arbea, L.
    Moreno, M.
    Azcona, D.
    Ramos, L.
    Barbes, B.
    Santisteban, M.
    Gil Bazo, I.
    Idoate, M. A.
    Garcia de Eulate, M. R.
    Tejada, S.
    Diez Valle, R.
    Aristu, J. J.
    NEURO-ONCOLOGY, 2018, 20 : 251 - 252
  • [26] Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases
    Musunuru, Hima B.
    Witt, Jacob S.
    Yadav, Poonam
    Francis, David M.
    Kuczmarska-Haas, Aleksandra
    Labby, Zacariah E.
    Bassetti, Michael F.
    Howard, Steven P.
    Baschnagel, Andrew M.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (02) : 385 - 390
  • [27] Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases
    Hima B. Musunuru
    Jacob S. Witt
    Poonam Yadav
    David M. Francis
    Aleksandra Kuczmarska-Haas
    Zacariah E. Labby
    Michael F. Bassetti
    Steven P. Howard
    Andrew M. Baschnagel
    Journal of Neuro-Oncology, 2019, 145 : 385 - 390
  • [28] Hypofractionated stereotactic radiotherapy to surgical cavity after resection for brain metastasis
    Yu, Hsiang-Hsuan M.
    Tsai, Ya-Yu
    CANCER RESEARCH, 2012, 72
  • [29] A phase II trial of stereotactic radiosurgery boost following surgical resection for solitary brain metastases.
    Narayana, A.
    Chan, K.
    Brennan, C.
    Chang, J.
    Higgins, V.
    Lymberis, S.
    Yamada, J.
    Gutin, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 71S - 71S
  • [30] A pilot study of concurrent chemotherapy (teniposide and carboplatin) combined with whole brain radiotherapy in non-small cell lung cancer patients with brain metastases.
    Kowalski, DM
    Krzakowski, MJ
    Jaskiewicz, P
    Zajda, K
    Wierzchowski, M
    Denisso, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 699S - 699S